A Case of Pleuroparenchymal Fibroelastosis
Language English Country Czech Republic Media print
Document type Journal Article, Case Reports
PubMed
40026161
DOI
10.14712/23362936.2025.5
PII: pmr_2025126010030
Knihovny.cz E-resources
- Keywords
- Pleuroparenchymal fibroelastosis, Postoperative, Prognosis, Weight loss,
- MeSH
- Fatal Outcome MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Fibrosis * diagnosis MeSH
- Tomography, X-Ray Computed MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Pleuroparenchymal fibroelastosis (PPFE) is a rare fibrotic lung disease with a poor prognosis. Some patients with PPFE have prominent lesions in one upper lobe. Due to the unilateral nature of lesions, similarities between some patients of PPFE and unilateral upper field pulmonary fibrosis (unilateral upper-PF) have been indicated. A 55-year-old man was referred to our hospital with PPFE, which had developed dyspnea 9 months previously. He had undergone resection of renal cancer 64 months prior to the onset of PPFE. He was administered the antifibrotic drug nintedanib, but passed away due to respiratory failure 43 months after the onset. What were impressive points in the clinical course of this PPFE patient was the similarity to unilateral upper-PF, including his medical history, and the poor prognosis. Although very rare, we do believe that the information on medical history and progression in this patient might provide suggestion into the treatment of future patients with a similar trajectory.
Department of Respiratory Medicine Mito Kyodo General Hospital Mito Japan
Kanagawa Cardiovascular and Respiratory Center Yokohama Japan
References provided by Crossref.org